Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a respiratory illness with systemic immune cell activation, inflammation, widespread multiorgan dysfunction, and thrombosis.

Researchers from St Petersburg University and other scientific organizations have developed a method to identify inhibitors of the enzyme responsible for coronavirus replication. While investigating ...

SEATTLE, WA, UNITED STATES, March 12, 2026 /EINPresswire.com/ — International Long COVID Awareness Day is observed each year on March 15th. There is an urgent need for prevention, research, funding, ...

The introduction of highly effective direct-acting antivirals has transformed the HCV treatment landscape, enabling cure ...

High-dose Vitamin D doesn't reduce acute COVID severity but shows a promising signal for reducing Long COVID and brain fog.

The prevention and control of communicable disease relies on a number of well-established interventions. Vaccination, vector ...

SARS-CoV-2 and respiratory syncytial virus continue to cause significant morbidity and mortality in the US, particularly among infants and older adults, underscoring the importance of vaccination, ...

On March 11, 2020, the World Health Organization officially declared COVID-19 a pandemic, "after more than 118,000 cases in 114 countries and 4,291 deaths" according to the CDC's website detailing a ...

Independent clinical validation strengthens ABL’s leadership in the fast‑growing HIV drug‑resistance testing market ABL ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...

Updated mRNA-1273 vaccine was effective against severe COVID-19 outcomes in older and high-risk adults during the 2024-2025 season.

Findings reveal coronaviruses exploit stress-linked tRNA modifications, enhancing translation efficiency and offering insights for antiviral drug development.